When does the pomalidomide patent expire?
A definitive “pomalidomide patent expiration date” depends on which specific patent(s) and jurisdictions you mean, because patents for a drug can include different claims (composition, formulations, methods of use) and have different expiry dates by country. Pomalidomide also has additional layers like patent term adjustments and regulatory exclusivity that vary by market.
How can I find the exact expiration date for pomalidomide in a specific country?
To get the correct expiry date, identify:
- The drug product/brand and manufacturer (different filings may exist for different markets).
- The jurisdiction (US, EU, UK, etc.).
- The patent family and the exact patent numbers covering pomalidomide in that country.
- Any regulatory exclusivity or extensions that affect market exclusivity even if a patent expires.
These details are usually published in national patent registers and in regulatory “patent and exclusivity” lists maintained for generics/drug approvals.
US: what matters for pomalidomide’s end of exclusivity (patents vs exclusivity lists)?
In the US, the key practical date for generic entry is often not a single patent expiry but the combination of:
- Expiration of relevant listed patents (linked to the reference drug product), and
- Regulatory exclusivity protections that can delay approval and marketing even after some patents end.
To pinpoint the date, you typically cross-check the reference drug in FDA’s listed patents/exclusivity records with the underlying patent expiry dates.
EU/UK: is it one date or several?
In the EU/UK, drug protection can involve multiple patents (and different legal protections), so “the” expiration date usually means the last-expiring relevant right for the relevant product in that territory, which can differ from other countries.
What if patents expire but the drug still can’t be marketed?
Even after patent expiry, market entry can be delayed by:
- Other still-active patents in the same patent family or related families, and/or
- Regulatory exclusivity mechanisms (which are not always tied to the same “patent expiration date”).
If you tell me your target market, I can narrow it down
If you share:
1) the country (e.g., US, Germany, UK),
2) the brand/company you mean (e.g., Pomalyst and the NDA holder), and
3) whether you want patent expiry or “generic launch” (market entry) date,
I can help you map which patent/exclusivity items are usually decisive and how to locate the exact expiry date for that market.
Sources: I don’t have the specific patent list or jurisdiction data needed to state an exact pomalidomide patent expiration date from the provided materials.